Membership
Prostate Cancer
About Prostate Cancer
Prostatitis
About Prostatitis
Prostatic Hyperplasia "Benign"
Good Sex & ED
Prostate Growth (BPH)
Update Newsletter
Financial Support
Members Comments
[ Home > Prostate Growth (BPH) ]

Click to enlarge

(BENIGN) PROSTATIC
HYPERPLASIA
“BPH”
PROSTATE GROWTH
WITHOUT CANCER

We put “Benign” in brackets because it is a complete mis-description of this prostate ailment. It borders on the ludicrous to call a condition “benign” when it –

reduces a man's ability to control his urination,

comes close to turning the life of senior men into misery, and

► if not properly cared for, can lead to extremely serious problems, not least of which are kidney damage or failure.

We call this condition simply “PH,” period.

The best thing you can say about PH is, it's not cancer. To make sure that point is clear, “PH” has nothing to do with cancer of the prostate (CaP). Vice versa, CaP has nothing to do with “PH.” A man can have either or both, making PH very common in CaP.

However, PH does seriously interfere with the use of PSA to diagnose cancer. An enlarged prostate puts out more PSA than one of normal size, a common cause of high PSA levels. Under the now-obsolete age/race adjusted PSA tables, PSAs above the levels in the tables very often promote biopsies that turn out negative. The use of PSA increases instead of PSA amounts should reduce this very real problem.

If you click on “newsletter,” you will find back issues filled with PH information. Our first PH issue answers 20 most-common questions. 3 more issues follow: Part I, Part II and Part III. Of special interest are the most recent issues reviewing two new PH treatments (Summer 2003) followed by “New Developments in PH Therapy,” Summer 2004.

Click for more information about UPDATE newsletters.




Prostate Growth (BPH)
Home | About us | Bicalutamide (Casodex) | Privacy policy | Donate
Copyright © 2005 - 2023 American Prostate Society. All rights reserved.
P.O. Box 870, Hanover, Maryland 21076.
Phone: +1-877-859-3735. E-Mail: [email protected]